SCHEMBL10044366

SCHEMBL10044366

COCCCNC(=O)CCCC(=O)N1C(=O)CCC1=O

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.64
HPGD P15428 3/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 2/20 0.44
RECQL P46063 1/20 0.43
GLA P06280 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 2/20 0.42
TP53 P04637 1/20 0.42
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12680023 0.93 TSHR (0.57) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL14275065 0.83 HPGD (0.43) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL10044365 0.81 SMN1; SMN2 (0.85) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL12417188 0.77 TSHR (0.54) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL10889100 0.77 SMN1; SMN2 (0.42) HPGDHTTSMN1; SMN2MEN1KMT2A
SCHEMBL17948493 0.76 NAMPT (0.38) TSHRHPGDHTTSMN1; SMN2KMT2A
SCHEMBL12013650 0.75 TSHR (0.88) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL4270085 0.75 TSHR (0.88) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL8574782 0.75 TSHR (0.88) TSHRHPGDHTTSMN1; SMN2MEN1
SCHEMBL12013653 0.75 TSHR (0.88) TSHRHPGDHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005985-B2 Optical reporter compositions APDN (B.V.I.) INC. (US) 2015-04-14 US disclosed
US-20130149706-A1 OPTICAL REPORTER COMPOSITIONS APDN (B.V.I.) Inc., dba Applied DNA Sciences, Inc. (US) 2013-06-13 US disclosed
US-8426216-B2 Methods for authenticating articles with optical reporters APDN (B.V.I.), Inc. (US) 2013-04-23 US disclosed
US-8420400-B2 System and method for authenticating tablets APDN (B.V.I.), Inc. (US) 2013-04-16 US disclosed
US-8415165-B2 System and method for authenticating sports identification goods APDN (B.V.I.), Inc. (US) 2013-04-09 US disclosed
US-20120252025-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS APDN, Inc. 2012-10-04 US disclosed
US-8124333-B2 Methods for covalent linking of optical reporters APDN, Inc. (VG) 2012-02-28 US disclosed
US-20090075261-A1 SYSTEM AND METHOD FOR AUTHENTICATING TABLETS APDN (B.V.I.) INC. (VG) 2009-03-19 US disclosed
US-20090042191-A1 SYSTEM AND METHOD FOR SECURE DOCUMENT PRINTING AND DETECTION APDN (B.V.I.) INC. 2009-02-12 US disclosed
US-20090042191-A1 SYSTEM AND METHOD FOR SECURE DOCUMENT PRINTING AND DETECTION APDN (B.V.I.) INC. 2009-02-12 US disclosed
US-20080312427-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS APDN (B.V.I.) INC. 2008-12-18 US disclosed
US-20080299559-A1 METHODS FOR AUTHENTICATING ARTICLES WITH OPTICAL REPORTERS APDN (B.V.I.) INC. 2008-12-04 US disclosed
US-20080293052-A1 SYSTEM AND METHOD FOR AUTHENTICATING SPORTS IDENTIFICATION GOODS APDN (B.V.I.) INC. 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312427-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS PCNA, POLL, LIG3 TSHR 3495/4885HPGD 3824/4885HTT 1153/4885
US-20120252025-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS PCNA, POLL, LIG3 TSHR 3495/4885HPGD 3824/4885HTT 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.